Original language | English |
---|---|
Pages (from-to) | 282-293 |
Number of pages | 12 |
Journal | British Journal of Haematology |
Volume | 194 |
Issue number | 2 |
Early online date | 16 Jun 2021 |
DOIs | |
Publication status | Published - Jul 2021 |
Bibliographical note
Funding Information:All the authors contributed to the writing of these guidelines. The writing committee would like to thank: the team of MDS experts at the MDS UK Patient Support Group for their critical review of the manuscript on behalf of the MDS UK Patient Support Group, Jacky Wilson for her help in undertaking the initial literature review, also the BSH Haemato-oncology Task Force, the BSH sounding board and the BSH Guidelines Committee for their support in preparing this guideline.
Keywords
- myelodysplastic syndromes
- MDS
- guideline
- diagnosis
ASJC Scopus subject areas
- Hematology